AstraZeneca chair says it is paying CEO enough to ward off US rivals

Drugmaker’s chief executive Pascal Soriot had talks last year about a role with US group Biogen#drugmaker #pascalsoriot #biogen
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: AstraZeneca | Health